Atrial fibrillation (AF) is an irregular, often rapid heartbeat that can increase the risk of blood clots, stroke, heart failure, and other cardiovascular complications. More than 2.7 million Americans are affected. AF often begins as brief, occasional episodes and may progress to longer or persistent episodes over time. Many people experience no symptoms, though some may notice palpitations, fainting, lightheadedness, shortness of breath, or chest discomfort.

Oxidative Stress, Inflammation, and AF

Research suggests that oxidative stress and inflammation play important roles in both heart failure and atrial fibrillation. Coenzyme Q10 (CoQ10), a compound involved in mitochondrial energy production and antioxidant defense, has been studied as a possible supportive therapy.

A study published in the Journal of Investigative Medicine (June 2015;63(5):735–739) evaluated whether CoQ10 could help reduce the incidence of AF in patients with heart failure.

Study Overview

The study included 102 patients, randomly assigned to two groups:

  • CoQ10 group: received CoQ10 along with their usual medications

  • Control group: continued their standard drug therapy only

Participants underwent:

  • 24-hour Holter monitoring

  • Doppler echocardiography

  • Measurement of inflammatory cytokines

  • Evaluation of malondialdehyde (MDA), a marker of oxidative stress

These assessments were performed at baseline, 6 months, and 12 months.

Key Findings

  • The CoQ10 group showed a significant reduction in malondialdehyde levels at 6 and 12 months—indicating lower oxidative stress.

  • The control group showed no similar reduction.

  • After 12 months, only 3 patients in the CoQ10 group experienced episodes of atrial fibrillation, compared with 12 patients in the control group.

Conclusion

The researchers concluded:

“Coenzyme Q10 as adjuvant treatment in patients with HF may attenuate the incidence of AF. The mechanisms of the effect perhaps have relation with the reduced levels of malondialdehyde.”

These findings suggest that CoQ10 may have a supportive role in reducing AF episodes in patients with heart failure, potentially through its antioxidant effects.

Educational only — not medical advice.